Theralogix Launches Ovasitol Plus: Advanced Support for Metabolic and Hormonal Health

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

ROCKVILLE, MD / ACCESS Newswire / January 21, 2025 / Theralogix, a leader in evidence-based nutritional supplements, proudly announces the launch of Ovasitol® Plus, an exciting advancement in inositol supplementation designed to support women's metabolic, hormonal, and ovarian health.*

Makers of the #1 inositol supplement for women for over a decade, Theralogix recognizes the need for premium, research-backed solutions specifically designed to support women's metabolic and hormonal concerns. Ovasitol Plus builds on the success of Theralogix's original Ovasitol® with an addition of high-quality nutrients that optimize myo-inositol absorption and enhance metabolic health.*

Ovasitol Plus features a research-backed 40:1 blend of myo-inositol and d-chiro-inositol, enhanced with alpha-lactalbumin, a unique whey protein that increases myo-inositol absorption and bioavailability.* In addition to superior inositol absorption, Ovasitol Plus includes chromium picolinate and vitamin D to support healthy insulin, blood sugar, and lipid levels.*

Beyond metabolic health, Ovasitol Plus promotes menstrual regularity, healthy ovulation, and hormone balance, offering an ideal option for those who have not achieved their desired results with inositol alone or who want additional metabolic support.*

Manufactured in the USA in a GMP-compliant facility, Ovasitol Plus meets the highest standards of quality and safety. Like all Theralogix products, it is independently tested and certified by a non-profit third-party organization, ensuring purity, content accuracy, and freedom from contaminants.

Ovasitol Plus is available now through the Theralogix website and Amazon.

Theralogix continues to raise the bar for premium, evidence-based nutritional supplements, providing trusted products recommended by healthcare professionals nationwide for more than two decades.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Contact Information

Shannon Mahon
smahon@theralogix.com
301.464.7210

.

SOURCE: Theralogix



View the original press release on ACCESS Newswire

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  270.64
-3.36 (-1.23%)
AAPL  312.06
-0.45 (-0.14%)
AMD  516.10
-1.99 (-0.38%)
BAC  51.60
+51.59 (1031900.00%)
GOOG  376.43
-9.69 (-2.51%)
META  632.51
-2.78 (-0.44%)
MSFT  450.24
+23.25 (5.45%)
NVDA  211.14
+211.12 (986535.51%)
ORCL  225.78
+22.08 (10.84%)
TSLA  435.79
-6.31 (-1.43%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.